Guangdong Marubi Biotechnology Co., Ltd. (SHA:603983)
China · Delayed Price · Currency is CNY 32.55
-0.45 (-1.36%)
At close: Feb 6, 2026
SHA:603983 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Net Income | 346.72 | 341.63 | 259.42 | 174.18 | 247.92 | 464.4 |
Depreciation & Amortization | 25.27 | 25.27 | 24.56 | 26.53 | 20.08 | 12.65 |
Other Amortization | 4.48 | 4.48 | 1.13 | 10.82 | 13.32 | 8.69 |
Loss (Gain) From Sale of Assets | -0.03 | -0.03 | -0.52 | -0.31 | -0.42 | - |
Asset Writedown & Restructuring Costs | 0.31 | 0.31 | 0.07 | 0.03 | 0.1 | 0.04 |
Loss (Gain) From Sale of Investments | -19.04 | -19.04 | -114.62 | -32.82 | -25.28 | -33.65 |
Provision & Write-off of Bad Debts | -0.16 | -0.16 | -2.42 | 2.14 | 1.33 | 0.02 |
Other Operating Activities | 108.23 | 22.87 | 37.84 | 6.24 | 4.38 | -7.31 |
Change in Accounts Receivable | -41.38 | -41.38 | -12.4 | -72.9 | -114.01 | -67.41 |
Change in Inventory | -60.16 | -60.16 | -33.08 | -25.21 | -13.96 | 42.79 |
Change in Accounts Payable | 61.91 | 61.91 | 184.7 | -22.09 | -150.3 | -81.3 |
Change in Other Net Operating Assets | 0.54 | 0.54 | - | -0.12 | 0.09 | 22.39 |
Operating Cash Flow | 390.98 | 300.53 | 338.02 | 48.44 | -7.48 | 362.35 |
Operating Cash Flow Growth | 15.47% | -11.09% | 597.88% | - | - | -22.17% |
Capital Expenditures | -232.22 | -316.37 | -254.05 | -110.91 | -117.14 | -748.91 |
Sale of Property, Plant & Equipment | 0 | 0 | 0 | 0.02 | 0.01 | 0.02 |
Cash Acquisitions | - | - | - | 0 | 0 | 0 |
Divestitures | 3.2 | 3.2 | - | 8.99 | 2.03 | - |
Investment in Securities | 440.66 | 736.01 | 6.76 | 169.51 | -572.79 | -75.68 |
Other Investing Activities | -240.78 | 9.35 | 32.12 | 2.53 | 6.76 | 42.48 |
Investing Cash Flow | -29.14 | 432.19 | -215.16 | 70.14 | -681.14 | -782.1 |
Short-Term Debt Issued | - | 150 | 100 | - | - | 107.28 |
Long-Term Debt Issued | - | - | - | 150 | - | - |
Total Debt Issued | -227.52 | 150 | 100 | 150 | - | 107.28 |
Short-Term Debt Repaid | - | -248 | -2 | - | -106.56 | - |
Long-Term Debt Repaid | - | -4.4 | -109.33 | -9.29 | -4.44 | - |
Total Debt Repaid | -154.4 | -252.4 | -111.33 | -9.29 | -111 | - |
Net Debt Issued (Repaid) | -381.92 | -102.4 | -11.33 | 140.71 | -111 | 107.28 |
Issuance of Common Stock | - | - | - | - | 25.86 | 0.8 |
Repurchase of Common Stock | - | - | -13.07 | -8.88 | -4.35 | - |
Common Dividends Paid | -301.84 | -313.16 | -106.11 | -76.77 | -141.92 | -156.83 |
Other Financing Activities | 195.69 | 222.41 | -14.8 | 89.87 | 61.56 | 23.9 |
Financing Cash Flow | -488.08 | -193.15 | -145.31 | 144.92 | -169.84 | -24.85 |
Foreign Exchange Rate Adjustments | 0.01 | -0.05 | 0.01 | -0.03 | -0.02 | 0.06 |
Net Cash Flow | -126.23 | 539.52 | -22.44 | 263.46 | -858.48 | -444.54 |
Free Cash Flow | 158.75 | -15.85 | 83.98 | -62.47 | -124.62 | -386.57 |
Free Cash Flow Growth | 427.61% | - | - | - | - | - |
Free Cash Flow Margin | 4.58% | -0.53% | 3.77% | -3.61% | -6.97% | -22.15% |
Free Cash Flow Per Share | 0.39 | -0.04 | 0.21 | -0.15 | -0.31 | -0.97 |
Cash Income Tax Paid | 304.23 | 257 | 238.25 | 262.56 | 250.59 | 229.25 |
Levered Free Cash Flow | 102.51 | -111.57 | 64.76 | -80.21 | -182.58 | -475.16 |
Unlevered Free Cash Flow | 107.85 | -105.41 | 68.9 | -78.19 | -181.94 | -474.46 |
Change in Working Capital | -74.8 | -74.8 | 132.57 | -138.37 | -268.91 | -82.49 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.